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Abstract
Background: The cellular and molecular mechanisms of adipose tissue biology have been studied extensively over
the last two decades. Adipose tissue growth involves both an increase in fat cell size and the formation of mature
adipocytes from precursor cells. To investigate how natural substances influence these two processes, we
examined the effects of lotus leaf extract (Nelumbo nucifera-extract solution obtained from Silab, France) and L-
carnitine on human preadipocytes and adipocytes.
Methods: For our in vitro studies, we used a lotus leaf extract solution alone or in combination with L-carnitine.
Utilizing cultured human preadipocytes, we investigated lotus leaf extract solution-induced inhibition of triglyceride
incorporation during adipogenesis and possible effects on cell viability. Studies on human adipocytes were
performed aiming to elucidate the efficacy of lotus leaf extract solution to stimulate lipolytic activity. To further
characterize lotus leaf extract solution-mediated effects, we determined the expression of the transcription factor
adipocyte determination and differentiation factor 1 (ADD1/SREBP-1c) on the RNA- and protein level utilizing qRT-
PCR and immunofluorescence analysis. Additionally, the effect of L-carnitine on beta-oxidation was analyzed using
human preadipocytes and mature adipocytes. Finally, we investigated additive effects of a combination of lotus
leaf extract solution and L-carnitine on triglyceride accumulation during preadipocyte/adipocyte differentiation.
Results: Our data showed that incubation of preadipocytes with lotus leaf extract solution significantly decreased
triglyceride accumulation during adipogenesis without affecting cell viability. Compared to controls, adipocytes
incubated with lotus leaf extract solution exhibited a significant increase in lipolysis-activity. Moreover, cell
populations cultivated in the presence of lotus leaf extract solution showed a decrease in adipocyte differentiation
capacity as indicated by a decrease in the ADD1/SREBP-1c signal. Importantly, our results demonstrated that a
combination of lotus leaf extract solution and L-carnitine reduced triglyceride accumulation to a greater extent
compared to incubation with either substance alone.
Conclusions: Overall, our data demonstrate that a combination of lotus leaf extract and L-carnitine reduced
triglyceride accumulation in human (pre)adipocytes by affecting different processes during the adipocyte life cycle.
For this reason, this combination might represent a treatment option for obesity-related diseases.
Background
Throughout industrialized countries, the prevalence of
obesity has increased dramatically during the last dec-
ades. Since obesity is closely associated with a number
of disorders including Type 2 diabetes, hypertension and
atherosclerosis, the prevention and treatment of this dis-
ease are of major concern [1].
Obesity occurs when the body’s energy intake exceeds
the body’s energy consumption for a prolonged period
of time. The degree of obesity is characterized by the
volume and number of adipocytes, which is regulated in
the so called adipocyte life cycle [2]. Thus, treatments
targeting the regulation of adipocyte size and number
may provide a therapeutic approach [3,4].
Several plant extracts and their respective bioactive
components are well recognized for their potential to
exert anti-obesity effects [2]. In this context, we focused
on lotus leaf extract, a natural plant extract, obtained
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is also known as the sacred lotus and all parts of this
plant have been used as traditional medicines in China
and India [5]. Lotus leaf extract contains multiple bioac-
tive components such as flavonoids [6], flavonoid glyco-
sides [7] and alkaloids [8]. In obese mice, it has been
reported that lotus leaf extract prevented the increase in
body weight, inhibited absorption of lipids and carbohy-
drates, accelerated lipid metabolism and up-regulated
energy expenditure, suggesting beneficial effects for the
suppression of obesity [9]. Also in mice, it was shown
that a 50% ethanol extract prepared from the leaves of
Nelumbo nucifera stimulated lipolysis in the white adi-
pose tissue [6]. However, to our knowledge conclusive
studies investigating effects of lotus leaf extract on tri-
glyceride accumulation or lipolysis-activity in human
cells are lacking so far.
Various natural phytochemicals influencing the adipo-
cyte life cycle have been identified. According to Raya-
lam et al. [2] a selective mono-therapy aiming to
prevent or treat obesity has not yet been successfully
established. However, the combined use of several nat-
ural products, which stimulate different molecular and
cellular mechanisms, might represent a more promising
approach to treat obesity. Adipose tissue lipolysis leads
to the breakdown of triglycerides stored in fat cells and
the subsequent release of fatty acids and glycerol. These
released fatty acids are transported into the circulatory
system and are processed by the liver. Single compo-
nents upon returning to the adipose tissue can be con-
verted back into adipocyte triglyceride. To prevent this
process, stimulation of beta-oxidation and, thus, the
removal of fatty acids (by creating energy) might help to
decrease fat stores more efficiently [10-12].
To determine to which extent lotus leaf extract influ-
ences adipogenesis and induces lipolysis-activity, we
investigated the effects of a lotus leaf extract solution on
human preadipocytes and adipocytes. Since L-carnitine
functions as a stimulant for the oxidation of fatty acids,
we additionally determined the possibility of combined
effects of lotus leaf extract and L-carnitine in human
(pre)adipocytes.
Methods
Test substances
Lotus leaf extract solution
For our studies, a liquid leaf extract of Nelumbo nucifera
(Pro-Sveltyl OP®; Lot 621021 and 621031; Silab, Brive,
France) designated as ‘lotus leaf extract solution’ was used.
This liquid extract solution is obtained from Nelumbo
nucifera leafs and comprises of a dry matter content of
approximately 6.4 mg/ml in a 50% aqueous butylene glycol
solution. To control for possible effects induced by the
butylene glycol solution, an aqueous 50% butylene glycol
solution in the respective concentration was used as
control.
L-carnitine
The second substance used for our experiments was L-
carnitine (L-Carnipure crystalline; Lot 00002; Lonza,
Basel, Switzerland). For experiments on beta-oxidation,
L-carnitine was dissolved directly in the respective cell
culture medium. In fat accumulation experiments, L-
carnitine was dissolved in cell culture medium in the
presence of 0.25% butylene glycol. This experiment
allowed us to compare the L-carnitine-induced effects
with the actions mediated by the combination of L-
carnitine and 0.5% lotus leaf extract solution which had
a final concentration of 0.25% butylene glycol. The
respective control was treated accordingly.
Differentiation of preadipocytes into adipocytes
Subcutaneous human preadipocytes isolated from the
abdomen, thigh and waist of different healthy subjects
(LOT L012202, L060403T, L052206) were obtained
from Zen-bio Inc. (Research Triangle Park, NC). Human
adipose derived stem cells (hADSC, LOT 7F3400) were
obtained from Cambrex (Verviers, Belgium). Cells
were cultured as previously described [13]. Briefly, cells
were incubated in basal growth medium (PGM, Cam-
brex, Verviers, Belgium) containing 10% fetal calf serum
(FCS), 2 mM L-glutamine, 100 U/ml penicillin and 100
μg/ml streptomycin (Cambrex, Verviers, Belgium) for 7
days at 37°C and 5% CO2 with medium change taking
place at day 1 and 4 after seeding. Following incubation,
cells were seeded into 96-well plates (1 × 10
4 per well)
or 6-well plates (3 × 10
5 per well), and after incubation
overnight the differentiation into adipocytes was
initiated by addition of 10 μg/ml insulin, 1 μMd e x a -
methasone, 200 μM indomethacin and 500 μM isobutyl-
methylxanthine (Cambrex, Verviers, Belgium) to the
medium. Culture medium containing these ingredients
is designated as ‘differentiation medium’. Cells cultured
for 7 days or more post induction of differentiation, are
referred to as adipocytes, while cells cultured without
the differentiation stimulus are termed preadipocytes.
For our studies we used cells up to the third passage.
Determination of cell viability
A viability assay determining the endogenous esterase
activity was used as previously described [14] to evaluate
possible cytotoxic effects of lotus leaf extract solution.
Briefly, preadipocytes were cultured for 7 days in ‘differ-
entiation medium’ containing 0.5%, 1% lotus leaf extract
solution or the respective control solution. Subsequently,
cells were washed with 1× Dulbecco’sP h o s p h a t eB u f -
fered Saline (DPBS) (Cambrex, Verviers, Belgium) and
incubated for 20 min in 100 μl fluorescein diacetate
(FDA; Sigma, Taufkirchen, Germany) solution (15 μg/ml
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(excitation at 491 nm/emission at 517 nm) using the 96-
well plate reader Safire 1 (Tecan, Crailsheim, Germany).
Determination of triglyceride accumulation
For experiments, preadipocytes were cultivated for 7
days in ‘differentiation medium’ supplemented with 0.5%
or 1% lotus leaf extract solution, 0.01% L-carnitine, a
combination of 0.01% L-carnitine and 0.5% lotus leaf
extract solution or the respective control solutions.
The accumulation of triglycerides during differentia-
tion was determined on day 7 using an AdipoRed Assay
(Cambrex, Verviers, Belgium) according to the manufac-
turer’s instructions. Fluorescence was detected (excita-
tion at 485 nm/emission at 572 nm) and quantified in a
96-well plate reader Safire 1 (Tecan, Crailsheim,
Germany).
For additional microscopic analysis, cells were incu-
b a t e dw i t hA d i p o R e dr e a g e n tf o r1 0m i na tr o o mt e m -
perature. Samples were analyzed by fluorescence
microscopy using an Olympus IX71 microscope (Ham-
burg, Germany).
Determination of glycerol release
Subcutaneous human preadipocytes or hADSCs were
seeded in cell culture flasks (9 × 10
3 cells/cm
2)a n dc u l -
tured in Dulbecco’s modified Eagle Medium-F12
(Gibco/BRL, Eggenstein, Germany) containing 10% FCS,
0.5% gentamycin (Gibco/BRL, Eggenstein, Germany), 33
μMb i o t i na n d1 7μM D-pantothenate (Sigma, Tauf-
kirchen, Germany) at 37°C and 5% CO2.A f t e r7d a y s ,
cells were transferred into 96-well plates (10
5 cells/well).
One day later, the medium was replaced with fresh
medium containing 10% FCS, 0.5% gentamycin, 33 μM
biotin, 17 μM D-pantothenate, 66 nM insulin, 1 nM T3,
100 nM hydrocortisol, 0.1 μg/ml apo-Transferrin and 1
μg/ml ciglitazone (all obtained from Sigma, Taufkirchen,
Germany). After 3 days, the medium was substituted for
medium of the same composition but lacking ciglita-
zone. Three days later, this medium was replaced by
‘differentiation medium’ and, cells were cultivated for 2
additional weeks.
Prior to incubation with test substances, the differen-
tiated cells were cultured for one week in Dulbecco’s
modified Eagle Medium low Glucose (Cambrex, Ver-
viers, Belgium) supplemented with 1% Bovine Albumin
Fraction V, 100 U/ml penicillin, 100 μg/ml streptomycin
and 1× Glutamax (all obtained from Gibco/BRL, Eggen-
stein, Germany). This culture medium is designated as
‘maintenance medium’. Glycerol release was analyzed 28
days post induction of differentiation.
For experiments, cells were incubated in 200 μl ‘main-
tenance medium’ containing either 0.5% or 1% lotus leaf
extract solution or control solution for 24 h at 37°C and
5% CO2. Free glycerol reagent and standard solution
(Sigma, Taufkirchen, Germany, standard dilution: 125 to
1.95 μg/ml (1:1 mix ratio steps)) were used according to
the manufacturer’s instructions.
For measurement, 100 μl cell supernatant were
obtained from each well and mixed with 100 μl free gly-
cerol reagent using a 96-well plate. After 15 min of
incubation at room temperature in the dark, absorption
was measured in a Spectra MAX 96-well plate reader
(Molecular Devices, Union City, CA) at 540 nm.
Quantification of ADD1/SREBP-1c gene expression
Subcutaneous human preadipocytes were cultured as
described above. For experiments, cells were cultivated
for 3, 6 and 9 days in ‘differentiation medium’ with or
without 1% lotus leaf extract solution. Cells were har-
vested on day 3, 6 and 9 after induction of differentia-
tion and homogenized in TRIzol® (Invitrogen, Karlsruhe,
Germany) following the manufacturer’sp r o t o c o l .A f t e r
reverse transcription, samples were analyzed for the adi-
pocyte determination and differentiation factor 1
(ADD1/SREBP-1c) by Real-Time TaqMan®-PCR using
the 7900HT Fast-Real-Time PCR System (Applied Bio-
systems, Darmstadt, Germany).
FAM labelled primers for qRT-PCR (Applied Biosys-
tems, Forster City, CA) were as follows: Inventoried
TaqMan Assays for the internal control glyceraldehyde-
3-phosphate dehydrogenase (GAPDH; Hs99999905_m1)
and for the target RNA ADD1/SREBP-1c
(Hs01088691_m1). TaqMan® Fast Universal PCR Master
Mix (Applied Biosystems, Forster City, CA) was used
and the PCR was performed as recommended by the
supplier. Real-time PCR data were analyzed using the
Sequence detector version 2.3 software supplied with
the 7900HT Fast-Real-Time PCR System (Applied Bio-
systems, Darmstadt, Germany). Quantification was
achieved using the 2
-ΔΔCt method which calculates the
relative changes in gene expression of the target normal-
ized to an endogenous reference (GAPDH).
Immunofluorescence microscopic analysis
For immunofluorescence analysis, preadipocyte popula-
tions were grown on coverslips and incubated in ‘differ-
entiation medium’ with or without 1% lotus leaf extract
solution for 9 days as described above. Next, cells were
fixed with 4% formaldehyde solution for 30 min at room
temperature, washed with phosphate buffered saline
(PBS) and permeabilized with 0.2% Triton X-100. After
successive washing with PBS, fixed cells were pre-treated
with PBS containing 10% donkey-serum for 30 min.
Cells were then incubated for 1 h with primary antibo-
dies directed against ADD1/SREBP-1c (sc 8984; Santa
Cruz, Heidelberg, Germany). Coverslips were succes-
sively rinsed three times with PBS, and then incubated
for 1 h with a secondary antibody labeled with Cy3. Cell
nuclei were stained using Hoechst 33342 (1 μg/ml; Invi-
trogen, Karlsruhe, Germany). Results were determined
using the Fluorescence microscope IX71 in combination
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Germany).
Determination of beta-oxidation
For determination of beta-oxidation, subcutaneous
human preadipocytes were cultured according to the
manufacturer’s instructions as described above. Preadi-
pocytes (300,000 cells/dish) were seeded into sterile 3.3
cm Nunclon Petri dishes (Nunc, Roskilde, Denmark) in
PGM. The next day, beta-oxidation was measured as
described below.
With respect to adipocyte populations, differentiation
was induced by adding 10 μg/ml insulin, 1 μMd e x a -
methasone, 200 μM indomethacin and 500 μM isobutyl-
methylxanthine (Cambrex, Verviers, Belgium) to the
medium. Cells were cultured for 2 weeks with one med-
ium change taking place after one week of culture. Prior
to determination of beta-oxidation, adipocytes were
incubated for 7 days in ‘maintenance medium’.
For experiments, adipocytes were cultivated in ‘mainte-
nance medium’ with and without 0.01%, 0.025% and 0.1%
L-carnitine while preadipocytes were incubated with
0.1% L-carnitine, 0.5% or 1% lotus leaf extract solution
solved in PGM. The medium was additionally supple-
mented with 8.8 μM
14C-labeled palmitic acid (Amer-
sham Buchler GmbH, Braunschweig, Germany). Each
dish was incubated for 18 h at 37°C in a sealed 125 ml
Nalgene sterile plastic container (Nunc, Roskilde,
Denmark) equipped with a rubber septum in its lid. In
addition, the container contained a 2 ml reaction tube
located in a purpose-built reck. Following incubation, 1
ml benzethonium hydroxide solution (Sigma-Aldrich,
Steinheim, Germany) was injected as a
14CO2 scavenger
into the reaction tube via the rubber septum using a syr-
inge with a cannula. Cells were then lysed and
14CO2 was
driven out by the injection of 600 μL of 7% trichloroace-
tic acid into the cell supernatant via the rubber septum.
Following an incubation of 2 h at room temperature
under gentle shaking, the sealed system was opened and
the
14CO2 scavenger solution was transferred into a scin-
tillator cup. Two mL of Ultima Gold scintillator liquid
(Perkin Elmer, Boston, MA) were added and radioactivity
was determined using a Beckman LS6500 liquid scintilla-
tion counter device (Beckman Coulter, Brea, CA). The
amount of radioactive
14CO2 served as a measure for the
quantity of beta-oxidation. Counts of control samples
cultivated without L-carnitine or lotus leaf extract solu-
tion were set as 100%.
Statistical analysis
A significance level of 0.05 (alpha) was chosen for statis-
tical analysis, based on two-sided hypothesis testing.
The following analysis was performed:
Check of normal distribution by means of Shapiro-
Wilk’s test.
Comparison versus control by means of repeated mea-
sures ANOVA with treatment as classification variable.
Comparison between experiments by means of
ANCOVA with treatment as classification variable and
control as covariable.
Where required, post-hoc pairwise comparison by
means of generalized Tukey test.
Software used: SAS software package for Windows
V9.1.3.
Results
Lotus leaf extract solution decreased triglyceride
accumulation during adipogenesis
To investigate effects of lotus leaf extract solution on
triglyceride accumulation during human preadipocyte/
adipocyte differentiation, cells were cultured in ‘differen-
tiation medium’ for 7 days in the absence or presence of
lotus leaf extract solution. As displayed in Figure 1A,
the majority of control cells showed an accumulation of
triglycerides in the lipid droplets. In contrast, most cells
incubated with 1% lotus leaf extract solution did not
accumulate triglycerides as indicated by the absence of
yellow staining.
To quantify these results, the total amount of trigly-
ceride accumulation during (pre)adipocyte differentia-
tion was determined (Figure 1B). Cells were cultured in
the absence or presence of 0.5% (n = 12) or 1% (n = 12)
lotus leaf extract solution. The results showed that lotus
leaf extract solution decreased triglyceride accumulation
in a dose-dependent manner. Cells treated with ‘differ-
entiation medium’ containing 0.5% lotus leaf extract
solution significantly (p < 0.0001) decreased triglyceride
levels to 77 (± 3.4)% compared to control cells (set as
100%) whereas incubation with 1% lotus leaf extract
solution significantly reduced (p < 0.0001) triglyceride
accumulation to 46 (± 5.9)%.
In addition, a viability assay was used to determine
any possible adverse effects of 0.5% (n = 12) or 1% (n =
12) lotus leaf extract solution. As illustrated in Figure
1C, control cells (set as 100%) and maturing adipocytes
cultivated with 0.5% (100 ± 4.9%) or 1% lotus leaf
extract solution (97 ± 6%) displayed comparable esterase
activities indicating that the viability of cultured cells
was not affected by incubation with lotus leaf extract
solutions.
Lotus leaf extract solution stimulated lipolysis-activity in
differentiated adipocytes
To address the question whether lotus leaf extract solu-
tion also stimulates lipolysis-activity by degrading trigly-
cerides into free fatty acids and glycerol, we determined
glycerol release from cell populations (n = 18) cultivated
in the presence or absence of lotus leaf extract solution.
As our studies showed (Figure 2), treatment of adipocyte
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cantly (p < 0.0001) increased the content of free glycerol
to 356 (± 76)% compared to control cells (set as 100%).
Likewise, cultivation of cells with 1% lotus leaf extract
solution induced a significant (p < 0.0001) release of
free glycerol to 340 (± 80)% compared to control cells.
Effects of lotus leaf extract solution on ADD1/SREBP-1c
mRNA- and protein levels
To gain insight into the molecular events associated
with the above described inhibition of triglyceride accu-
mulation, cells were cultivated in the presence or
absence of 1% lotus leaf extract solution. Three, 6 and 9
days after initiation of differentiation, gene expression of
the essential adipogenic transcription factor ADD1/
SREBP-1c was determined relative to control cells by
quantitative RT-PCR (Figure 3A; n = 3). Compared to
control cells (set as 100%), pre(adipocytes) incubated
with 1% lotus leaf extract solution displayed a decrease
in ADD1/SREBP-1c mRNA levels over time.
To investigate if the effects of lotus leaf extract solu-
tion on ADD1/SREBP-1c gene expression translate to
the protein level, we incubated cells with 1% lotus leaf
extract solution and determined the expression of
ADD1/SREBP-1c using immunofluorescence analysis. In
agreement with our previous findings, cells incubated
with lotus leaf extract solution (Figure 3B b and 3B d)
displayed only a weak ADD1/SREBP-1c signal compared
to the control cells (Figure 3B a and 3B c). Notably, the
number of nuclei, stained with Hoechst 33342, was
comparable in all investigated areas.
In summary, the results indicated that lotus leaf
extract solution affects adipogenesis.
Determination of effects of L-carnitine on beta-oxidation
To characterize a possible effect of L-carnitine and lotus
leaf extract solution on beta-oxidation in human
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Figure 1 Lotus leaf extract solution decreased triglyceride
accumulation during preadipocyte/adipocyte differentiation. (A)
Images after triglyceride staining (yellow) from cell populations
incubated with and without 1% lotus leaf extract solution. Scale bar:
200 μm. (B) Triglyceride accumulation of maturing human
adipocytes incubated with 0.5% or 1% (n = 12, each) lotus leaf
extract solution relative to untreated control cells (n = 12) set as
100%. Results are depicted as mean ± SD. (C) Cell viability of
maturing adipocytes cultivated in ‘differentiation medium’ with 0.5%
or 1% lotus leaf extract solution (n = 12, each) compared to
untreated control cells set as 100%. Results are depicted as mean ±
SD. Significant differences are marked with an asterisk (* for p <
0.0001 against control).
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Figure 2 Increase in glycerol release from differentiated
adipocytes after incubation with lotus leaf extract solution.
Glycerol release from differentiated human adipocytes after
treatment with 0.5 or 1% lotus leaf extract solution (n = 18)
compared to untreated control cells set as 100%. Results are
depicted as mean ± SD. Significant differences are marked with an
asterisk (* for p < 0.0001 against control).
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Page 5 of 10preadipocytes (n = 7) and differentiated adipocytes (n =
14), cells were incubated with L-carnitine, lotus leaf
extract solution or without as described in the figure
legend. As depicted in Figure 4A and 4B, the release of
radioactively-labeled CO2 was significantly (p < 0.0001)
augmented in preadipocyte populations cultivated in the
presence of 0.1% L-carnitine (272 ± 48%) compared to
controls (set as 100%). Similar results were observed in
adipocyte cell cultures (240 ± 39%). In addition, in adi-
pocyte populations an increase in radioactively-labeled
CO2 was also observed when 0.025% (227 ± 46%) and
0.01% (269 ± 67%) L-carnitine was used, indicating that
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Figure 3 Effect of lotus leaf extract solution on ADD1/SREBP-1c expression during adipogenesis. (A) ADD1/SREBP-1c gene expression in
differentiating preadipocytes after incubation with 1% lotus leaf extract solution compared to control cells set as 100%. Expression of ADD1/
SREBP-1c is normalized to GAPDH. Three independent experiments were prepared both for control and incubation with lotus leaf extract
solution (n = 3). Results are depicted as mean ± SD. (B) Human preadipocyte populations were cultured in ‘differentiation medium’ without (a, c)
or with (b, d) 1% lotus leaf extract solution for 9 days. Immunofluorescence staining of ADD1/SREBP-1c (red) and of DNA (Hoechst-33342 (blue))
was performed. a and b: Scale bar: 200 μm; c and d: Scale bar: 50 μm.
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oxidation. In contrast, preadipocyte incubation with
0.5% or 1% lotus leaf extract solution did not sufficiently
affect the release of radioactively-labeled CO2.
Additive effects of lotus leaf extract solution and L-
carnitine on triglyceride accumulation
Our previous results showed that L-carnitine stimulated
beta-oxidation in preadipoc y t e sa sw e l la si nm a t u r e
adipocytes. Therefore, we investigated if a combined
treatment of cells with L-carnitine and lotus leaf extract
solution might result in a pronounced reduction of tri-
glyceride accumulation during preadipocyte/adipocyte
differentiation. As our data showed (Figure 5), com-
pared to the respective control (set as 100%), incubation
of cells with 0.01% L-carnitine (n = 10) or 0.5% lotus
leaf extract solution (n = 12) alone induced a significant
decrease in triglyceride accumulation to 81 (± 9.6)%
(p = 0.0001) and 77 (± 3.4)% (p < 0.0001), respectively.
However, supplementation of the cell culture medium
with a combination of 0.01% L-carnitine and 0.5% lotus
leaf extract solution (n = 12) reduced triglyceride levels
significantly (p < 0.0001) to 60 (± 5.7)% compared to
control cells (set as 100%). In addition, triglyceride
levels of cells incubated with L-carnitine and lotus leaf
extract solution were significantly (p < 0.0001, each)
lower than triglyceride levels of cell populations which
were cultivated in the presence of only one of the two
actives.
Discussion
The simultaneous regulation of different mechanisms
involved in fat metabolism utilizing multiple natural
compounds might be an appropriate approach to
increase anti-obesity treatment efficiently. To put this
approach into practice, we aimed to identify active
ingredients that stimulate different processes. In a sec-
ond step, we tested if a combination of these ingredients
is able to cause a sustained decrease in fat stores.
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Figure 4 L-carnitine stimulated beta-oxidation in preadipocytes
and differentiated adipocytes. (A) Preadipocytes were incubated
with 0.1% L-carnitine, 0.5% and 1% lotus leaf extract solution or left
untreated as control for 18 h (n = 7). (B) Differentiated adipocytes
were cultivated with 0.01%, 0.025% or 0.1% L-carnitine and
untreated cells served as control (n = 14).
14CO2 counts emitted by
control samples were set as 100%. The threshold for relevant
differences was set at 150%. Results are depicted as mean ± SD.
Significant differences are marked with an asterisk (* for p < 0.0001
against control).
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Figure 5 Additive effect of lotus leafe x t r a c ts o l u t i o na n dL -
carnitine on triglyceride accumulation during preadipocyte/
adipocyte differentiation. Treatment of preadipocytes with 0.01%
L-carnitine (n = 10), 0.5% lotus leaf extract solution (n = 12) or a
combination of 0.01% L-carnitine and 0.5% lotus leaf extract
solution (n = 12) on triglyceride accumulation during preadipocyte/
adipocyte differentiation. Triglyceride levels of the respective control
samples were set as 100%. Results are depicted as mean ± SD.
Significant differences are marked with an asterisk (* for p ≤ 0.0001
against control; ** for p ≤ 0.0001 against control and all other
treatments).
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effects of lotus leaf extract solution on triglyceride accu-
mulation and lipolysis-activity in human (pre)adipocytes.
As our data demonstrate, incubation with 1% lotus
leaf extract solution decreased the number and content
of lipid droplets during preadipocyte differentiation
compared with control cells. In addition, both 0.5% and
1% lotus leaf extract solution significantly reduced tri-
glyceride incorporation in human preadipocytes during
adipogenesis in a dose-dependent manner. Importantly,
this significant reduction in triglyceride accumulation
was not due to toxic side effects exerted by the lotus
leaf extract solution.
To investigate if the observed attenuation in triglycer-
ide incorporation during adipogenesis might be due to
the ability of lotus leaf extract solution to increase the
conversion of triglycerides to fatty acids and glycerol, we
measured the glycerol content in the supernatants of
differentiated adipocyte cultures. Interestingly, our
results show that lotus leaf extract solution significantly
augmented lipolysis-activity.
In the literature it has been reported that a number of
natural compounds inhibit adipogenesis on a molecular
level [2]. The complex sequence of preadipocyte differ-
entiation is initially triggered by transcription factor-
activated signaling pathways [15]. Three classes of tran-
scription factors are directly involved in adipogenesis:
the peroxisome proliferator-activated receptor g
(PPARg), the CCAAT/enhancer binding proteins (C/
EBPa, C/EBPß and C/EBPδ) and the adipocyte determi-
nation and differentiation factor 1 (ADD1/SREBP-1c)
[3]. ADD1/SREBP-1c is highly expressed in the liver and
in adipose tissue and plays a crucial part in adipocyte
differentiation [16]. ADD1/SREBP-1c mRNA levels are
augmented in determined preadipocytes and to a greater
extent increased during the differentiation process
[16,17]. In addition to its role in adipogenesis, ADD1/
SREBP-1c has been associated with the regulation of
genes linked to cholesterol metabolism. In this context,
ADD1/SREBP-1c has been termed sterol regulatory ele-
ment binding protein 1c (SREBP-1c) [18].
To study if incubation with lotus leaf extract solution
is associated with adipocyte differentiation, we investi-
gated potential alterations in the mRNA- and protein
levels of ADD1/SREBP-1c. Our results illustrate that dif-
ferentiated adipocytes displayed an augmented ADD1/
SREBP-1c mRNA and protein expression. Interestingly,
cells incubated in the presence of 1% lotus leaf extract
solution showed a decreased ADD1/SREBP-1c mRNA
expression. In addition, these cells exhibited only a weak
ADD1/SREBP-1c signal as determined by immunofluor-
escence analysis indicating that cultivation in the pre-
sence of lotus leaf extract solution affects adipocyte
differentiation.
According to our starting idea whether triglyceride
accumulation can be reduced to an even greater extent
by regulating another important process in fat metabo-
lism, we investigated the impact of L-carnitine (alone or
in combination with lotus leaf extract solution) on
human primary preadipocytes/adipocytes.
L-carnitine (b-hydroxy-g-trimethylaminobutyric acid),
a small, water-soluble, quaternary amine is known to
play a role in mammalian lipid catabolism and mainte-
nance of the body’s energy metabolism. In humans, its
homoeostasis is maintained by endogenous synthesis
performed by the kidney, liver and brain, absorption
from dietary sources and efficient tubular re-absorption
by the kidney. Its daily requirements are mainly satisfied
by diet. Major sources of L-carnitine in the human diet
are meat, fish and dairy products [19]. L-carnitine repre-
sents an essential cofactor for long-chain fatty acid oxi-
dation translocating long chain fatty acids across the
mitochondrial membranes into the mitochondrial
matrix, where beta-oxidation takes place. Through this
mechanism, it supports the degradation of fatty acids
and the concomitant production of biological energy in
the form of ATP.
The role of L-carnitine supplementation in obesity
treatment is discussed controversially in the scientific
literature. In healthy adults without L-carnitine defi-
ciency, fatty acid oxidation increased after L-carnitine
supplementation (3 g/day) for 10 days [20]. In addition,
in rats fed a high fat diet, L-carnitine supplementation
significantly decreased food intake, whole body weight
and adipose tissue accumulation [21]. On the other
hand, there are data suggesting that L-carnitine supple-
mentation is not effective in inducing changes in body
composition or weight reduction [22].
At the molecular level an anti-obesity effect of L-
carnitine is suggested by Lee and co-workers. They
demonstrated in 3T3-L1 cells that L-carnitine stimulates
lipolysis-activity and increases the expression of genes
involved in beta-oxidation [23]. Although the mouse
3T3-L1 cell line represents a well-established model sys-
tem to study fat metabolism [24], known species-related
differences in adipose tissue biology have to be taken
into account. For this reason, we utilized primary
cultured human cells throughout our experiments as
these cells represent a better in vitro model for humans.
I nl i n ew i t ht h es t u d ym e n t i o n e da b o v e[ 2 3 ] ,w e
detected a significantly augmented beta-oxidation in
human preadipocytes and differentiated adipocytes after
incubation with L-carnitine compared to control cells.
However, a stimulation of lipolysis-activity by L-carnitine
was not observed (data not shown). Furthermore, an
increase in beta-oxidation was not induced by lotus leaf
extract solution, showing that both ingredients act on dif-
ferent processes during the adipocyte life cycle.
Siegner et al. Nutrition & Metabolism 2010, 7:66
http://www.nutritionandmetabolism.com/content/7/1/66
Page 8 of 10Murosaki et al. [11] demonstrated combined effects of
L-carnitine, soy isoflavones, caffeine and arginine on tri-
glyceride accumulation, lipolysis-activity and fatty acid
oxidation using 3T3-L1 or HepG2 cells. Moreover, the
combination of these compounds significantly sup-
pressed lipogenesis in the liver when KK mice were
food-deprived for 48 h and subsequently re-fed a fat
free diet. In addition, body weight, adipose tissue weight,
and triglyceride levels in the plasma and liver were
reduced in obese KK mice given a low-fat diet. In a rat
model with high fat diet-induced obesity a mixture com-
posed of L-carnitine, G. cambogia extract and soy pep-
tide attenuated visceral fat accumulation and improved
dyslipidemia [25]. These reports support the notion that
L-carnitine used in combination with other natural
compounds of different origin can induce beneficial
effects in obesity treatment.
Based on the findings of Murosaki and co-workers
[11], we studied the combined effects of lotus leaf
extract solution and L-carnitine on triglyceride accumu-
lation during human preadipocyte/adipocyte differentia-
tion. In line with our previous results, incubation of
cells with 0.01% L-carnitine or 0.5% lotus leaf extract
solution alone induced a significant decrease in trigly-
ceride accumulation. However, compared with control
cells, supplementation of cell culture medium with a
combination of L-carnitine and lotus leaf extract solu-
tion resulted in an even greater reduction in triglyceride
levels, clearly pointing to an additive effect induced by
these two compounds. Nevertheless, the molecular path-
way(s) leading to the described additive effect will have
to be identified in future studies.
Although final confirmation is still lacking, it might be
speculated that the increased (lotus leaf extract solution-
induced) lipolysis-activity in combination with the aug-
mented (L-carnitine-induced) degradation of fatty acids
not only leads to an increase in triglyceride degradation
but also results in the elimination of triglycerides from
the metabolic system. With respect to anti-obesity treat-
ments, the last point is crucial, since accumulation of
mobilized fatty acids in other tissues such as muscle or
liver needs to be prevented.
Conclusion
A wide range of health problems is related to an impro-
per fat storage and release. Due to the increase in obe-
sity-related disorders, cellular and molecular processes
underlying fat metabolism have been investigated inten-
sely in recent years.
In this context, we aimed to test a combination of nat-
ural compounds influencing different processes during
the adipocyte life cycle to achieve synergistic and/or
additive effects on cellular fat reduction. Overall, our
data demonstrate that single treatment of primary
human (pre)-adipocytes with lotus leaf extract solution
modulated lipolysis-activity and also decreased adipo-
genesis. Additionally, L-carnitine augmented beta-oxida-
tion in primary human adipocytes. Importantly, the
combined treatment utilizing lotus leaf extract solution
and L-carnitine led to a significant reduction in trigly-
ceride accumulation compared to the single use of these
natural sources. By simultaneously stimulating different
pathways associated with fat storage a better potential
for the treatment and prevention of obesity might be
achieved.
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